About this Study
We are conducting a clinical trial of trauma-focused psychodynamic psychotherapy (24 sessions, delivered twice weekly over 12 weeks) for people living with HIV who may be experiencing post-traumatic stress (PTSD). All therapy is provided at no cost by experienced clinicians supervised by expert investigators.
Most sessions can be completed remotely. Study assessments occur at baseline, mid-treatment (week 5), post-treatment (week 12), and three months after treatment. We also collect saliva samples to measure biomarkers of stress.
Basic Eligibility
Inclusion
- Age 18–65
- HIV-positive
- Stable on psychotropic meds ≥ 2 months (if any)
- Willing to pause med changes during treatment*
Exclusion
- Current primary substance-use disorder
- Psychotic disorders or Bipolar I
- Unstable serious medical conditions
- Organic brain injury / intellectual disability
*Changes permitted in emergencies; our team will discuss details with you.
Frequently Asked Questions
Do I need a PTSD diagnosis before contacting you?
No. Our team will complete a thorough assessment to determine whether the study therapy is appropriate for you.
Is everyone randomized to different treatments?
No. This is not a randomized controlled trial. Every participant receives the same trauma-focused psychotherapy.
How long does the therapy last?
The protocol involves 24 sessions delivered twice weekly over approximately 12 weeks.
Do I need to travel to the clinic?
Most sessions can be conducted via secure video. A few study assessments require mailing or delivering saliva samples to Albert Einstein College of Medicine (Bronx, NY).